Active efflux of CPT-11 and its metabolites in human KB-derived cell lines

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 735-741

  Chu, Xiao Yan ^a   Suzuki, Hiroshi ^a   Ueda, Kaoru ^a   Kato, Yukio ^a   Akiyama, Shin Ichi ^b   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; ADENOSINE TRIPHOSPHATE; CARBOXYLIC ACID DERIVATIVE; DRUG METABOLITE; GLUTATHIONE; GLYCOPROTEIN P; IRINOTECAN; LACTONE DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN;

ACTIVE TRANSPORT; ARTICLE; CELL STRAIN KB; CONTROLLED STUDY; DRUG RESISTANCE; DRUG TRANSPORT; DRUG UPTAKE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MICHAELIS CONSTANT; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CAMPTOTHECIN; CELL MEMBRANE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; KB CELLS; LACTONES;

EID: 0032988933     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Akiyama S, Foji A, Hanover JA, Pastan I and Gottesman MM (1985) Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 11:117-126.
2. Borst P, Kool M and Evers R (1997) Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? Sem Cancer Biol 8:205-213.
3. Büchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T and Keppler D (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271:15091-15098.
4. Carmichael J, Degraff WG, Gazdar AF, Minna JD and Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 15:936-942.
5. Chu X-Y, Kato Y, Niinuma K, Sudo KI, Hakusui H and Sugiyama Y (1997a) Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. J Pharmacol Exp Ther 281:304-314.
6. Chu X-Y, Kato Y and Sugiyama Y (1997b) Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11 and its metabolites in rats. Cancer Res 57:1934-1938.
7. Chu X-Y, Kato Y, Ueda K, Suzuki H, Niinuma K, Tyson CA, Weizer V, Dabbs JE, Froehlich R, Green CE and Sugiyama Y (1998) Biliary excretion mechanism of CPT-11 and its metabolities in humans: Involvement of primary active transporters. Cancer Res 58:5137-5143.
8. 4 transporter in cisplatin-resistant human KB cells. Biochem Biophys Res Commun 226:158-165.
9. Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LCJM, Paulusma CC, Oude Elferink RPG, Baas F, Schinkel AH and Borst P (1998) Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 101:1310-1319.
10. Fassberg J and Stella VJ (1992) A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci 81:676-684.
11. 4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. J Natl Cancer Inst 86:1781-1784.
12. Gottesman MM, Pastan I and Ambudkar SV (1996) P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6:610-617.
13. Hasegawa S, Abe T, Naito S, Kotoh S, Kumazawa J, Hipfner DR, Deeley RG, Cole SPC and Kuwano M (1995) Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br J Cancer 71:907-913.
14. Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T and Sugiyama Y (1998) Hepatic expression of multidrug resistance-associated protein (MRP)-like proteins maintained in Eisai hyperbilirubinemic rats (EHBR). Mol Pharmacol 53:1068-1075.
15. Hoki Y, Fujimori A and Pommier Y (1997) Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein-overexpressing cell lines. Cancer Chemother Pharmacol 40:433-438.
16. Ishikawa T and Akimaru K (1996) Transport of glutathione S-conjugates from cancer cells: Function and structure of the GS-X pump, in Glutathione S-transferases: Structure, Function and Clinical Implications (Vermeulen NPE, Mulder GJ, Nieuwenhuyse H, Peters WHM and van Bladeren PJ eds) pp 199-211, Taylor and Francis, London.
17. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1997) Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 272:G16-G22.
18. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1998) Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J Biol Chem 273:1684-1688.
19. Keppler D and König J (1997) Hepatic canalicular membrane 5: Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 11:509-516.
20. Koike K, Kawabe T, Tanaka T, Toh S, Uchiumi T, Wada M, Akiyama, S, Ono M and Kuwano M (1997) A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res 57:5475-5479.
21. Kool M, de Haas M, Scheffer GL, Scheper RJ, Van Eijk MJT, Juijin JA, Baas F and Borst P (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57:3537-3547.
22. Lautier D, Canitrot Y, Deeley RG and Cole SPC (1996) Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol 52:967-977.
23. Loe DW, Deeley RG and Cole SPC (1996) Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 32A:945-957.
24. Madon J, Eckhardt U, Gerloff T, Stieger B and Meier PJ (1997) Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett 406:75-78.
25. Masuda M, Iizuka Y, Yamazaki M, Nishigaki R, Kato Y, Niinuma K, Suzuki H and Sugiyama Y (1997) Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res 57:3506-3510.
26. Meier PJ (1996) Hepatocellular transport systems: from carrier identification in membrane vesicles to cloned proteins. J Hepatol 24 (Suppl 1):29-35.
27. Minato K, Kanzawa F, Nishio K, Nakagawa K, Fujiwara Y and Saijyo N (1990) Characterization of an etoposide-resistant human small-cell lung cancer cell line. Cancer Chemother Pharmacol 26:313-317.
28. Müller M and Jansen PL (1997) Molecular aspects of hepatobiliary transport. Am J Physiol 272:G1285-G1303.
29. Müller M, Roelofsen H and Jansen PL (1996) Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein. Semin Liv Dis 16:211-220.
30. Oude Elferink RP, Meijer DK, Kuipers F, Jansen PL, Groen AK and Groothuis GM (1995) Hepatobiliary secretion of organic compounds: molecular mechanisms of membrane transport. Biochim Biophys Acta 1241:215-268.
31. Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P and Oude Elferink RP (1996) Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (Wash DC) 271:1126-1128.
32. Paulusma CC and Oude Elferink RP (1997) The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man. J Mol Med 75:420-428.
33. Slichenmyer WJ, Rowinsky EK, Donehower RC and Kaufmann SH (1993) The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst 85:271-291.
34. Sugiyama Y, Kato Y and Chu X-Y (1998) Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: Role of canalicular multispecific organic anion transporter and P-glycoprotein. Cancer Chemother Pharmacol 42:S44-S49.
35. Sumizawa T, Chuman Y, Sakamoto H, Iemura K, Almquist KC, Deeley RG, Cole SPC and Akiyama S-I (1994) Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein. Somat Cell Mol Genet 20:423-435.
36. Takigawa N, Ohnishi T, Ueoka H, Kiura K and Kimura I (1992) Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line. Acta Med Okayama 46:203-212.
37. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura, K, Akiyama S and Kuwano M (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistatit human cancer cell lines with decreased drug accumulation. Cancer Res 56:4124-4129.
38. Tanizawa A, Bertrand R, Kohlhagen G, Tabuchi A, Jenkins J and Pommier Y (1993) Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance. J Biol Chem 268: 25463-25468.
39. van Aubel RAMH, van Kuijck MA, Koenderink JB, Deen PMT, van Os CH and Russel FGM (1998) Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol Pharmacol 53:1062-1067.
40. Vore M, Hoffman T and Gosland M (1996) ATP-dependent transport of β-estradiol 17-(β-D-glucuronide) in rat canalicular membrane vesicles. Am J Physiol 271: G791-G798.
41. Yamaoka K, Tanigawara Y, Nakagawa T and Uno T (1981) A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobio-Dyn 4:879-885.
42. Yamazaki M, Suzuki H and Sugiyama Y (1996) Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res 13:497-513.